These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 938576)

  • 21. Observation on the properties of dopamine-beta-hydroxylase.
    Brown FC; Harralson JD
    J Neurochem; 1975 Mar; 24(3):467-70. PubMed ID: 1113122
    [No Abstract]   [Full Text] [Related]  

  • 22. Some observations on the interaction of dopamine-beta-hydroxylase and its natural inhibitors in the rat brain.
    Yu PH; Boulton AA; Wu PH
    Can J Biochem; 1976 Nov; 54(11):988-91. PubMed ID: 1000363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the inhibition of dopamine beta hydroxylase by thiono-sulfur containing compounds.
    Catignani GL; Neal RA
    Life Sci; 1975 Jun; 16(12):1915-21. PubMed ID: 1152617
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of dopamine -hydroxylase by 5-phenoxymethyl-2-oxazolidinethiones.
    Johnson GA; Kim EG; Boukma SJ; Lednicer D; Youngdale GA
    J Med Chem; 1972 Mar; 15(3):327-9. PubMed ID: 5059221
    [No Abstract]   [Full Text] [Related]  

  • 25. Intracellular distribution of endogenous inhibitors of dopamine -hydroxylase in bovine adrenal medulla.
    Kuzuya H; Negatsu T
    Biochem Pharmacol; 1972 Mar; 21(5):740-2. PubMed ID: 5063171
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of bidentate nitrogen heterocycles on dopamine beta-hydroxylase activity in vitro.
    Waterbury LD; Serrato C; Martinez GR
    Proc West Pharmacol Soc; 1989; 32():9-13. PubMed ID: 2780621
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of dopamine-beta-hydroxylase by spinochrome A and echinochrome A, naphthoquinone pigments of echinoids.
    Kuzuya H; Ikuta K; Nagatsu T
    Biochem Pharmacol; 1973 Nov; 22(21):2722-4. PubMed ID: 4763606
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of ATP upon dopamine-beta-hydroxylase.
    Laduron PM
    Biochem Pharmacol; 1975 Aug; 24(16):1547-9. PubMed ID: 1191313
    [No Abstract]   [Full Text] [Related]  

  • 29. Selective inhibition of dopamine-beta-hydroxylase in the peripheral tissues by 5-dimethyldithiocarbamylpicolinic acid; its effect on stress-induced ulcer, ethanol-induced sleep and blood pressure.
    Hidaka H; Hara F; Harada N; Hashizume Y; Yano M
    J Pharmacol Exp Ther; 1974 Dec; 191(3):384-92. PubMed ID: 4473535
    [No Abstract]   [Full Text] [Related]  

  • 30. [Relation between the membrane and soluble forms of dopamine beta-monooxygenase].
    Markosian KA; Paĭtian NA; Nalbandian RM
    Biokhimiia; 1990 Jan; 55(1):147-54. PubMed ID: 2344453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of substituted DL-3(5-benzazolyl)alanines as dopa and alpha-methyldopa analogs and their effects on dopamine beta-hydroxylase, tyrosinase and diphenoloxidase.
    Loriga M; Paglietti G; Sparatore F; Pinna G; Sisini A
    Farmaco; 1992 Apr; 47(4):439-48. PubMed ID: 1388592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme.
    Orcutt JC; Molinoff PB
    J Pharmacol Exp Ther; 1977 Sep; 202(3):590-600. PubMed ID: 894523
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of dopamine beta-hydroxylase by sulfhydryl compounds and the nature of the natural inhibitors.
    Nagatsu T; Kuzuya H; Hidaka H
    Biochim Biophys Acta; 1967 Jul; 139(2):319-27. PubMed ID: 6034675
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of vinblastine on catecholamine-biosynthetic enzymes in heart, sympathetic ganglion and adrenal glands of rats.
    Hanbauer I; Kopin IJ; Maengwyn-Davies GD; Thoa NB; Weise VK
    Br J Pharmacol; 1973 May; 48(1):106-12. PubMed ID: 4146761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical localization of dopamine- -hydroxylase in the peripheral and central nervous system.
    Fuxe K; Goldstein M; Hökfelt T; Joh TH
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):627-36. PubMed ID: 4944550
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of dopamine-beta-hydroxylase by carnosine.
    Izumi H; Hayakari M; Kondo Y; Takemoto T
    Tohoku J Exp Med; 1975 Sep; 117(1):101-2. PubMed ID: 1188926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of dopamine beta-hydroxylase by bidentate chelating agents.
    Townes S; Titone C; Rosenberg RC
    Biochim Biophys Acta; 1990 Feb; 1037(2):240-7. PubMed ID: 2306475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade by metal complexing agents and by catalase of the effects of arachidonic acid on platelets: relevance to the study of anti-inflammatory mechanisms.
    Vargaftig BB; Tranier Y; Chignard M
    Eur J Pharmacol; 1975 Aug; 33(1):19-29. PubMed ID: 1175685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PGE2, phenylephrine and dopamine-beta-hydroxylase release from rat adrenal in vitro.
    Boonyaviroj P; Seiden A; Gutman Y
    Biochem Pharmacol; 1977 Feb; 26(4):351-2. PubMed ID: 849327
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential release of noradrenaline, adrenaline and dopamine-beta-hydroxylase from the bovine adrenal [proceedings].
    Helle KB; Serck-Hanssen G
    J Physiol; 1978 Feb; 275():27P-28P. PubMed ID: 633116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.